Question Bank › Staircase quarter: best recent period just repor

Staircase quarter: best recent period just reported, and the next step up is already in hand

Calls Tested
457
Answered YES
4
Hit Rate
0.9%
rare by design

Bristol-Myers Squibb Company (BMY) — this company's answers

NO on the Q4 2016 call 2017-01-26 F
The model's full reasoning — Q4 2016 call → NO我们根据提供的财报电话会议记录来判断。管理层是否将刚报告的时期描述为公司近期历史上最强的时期之一,并且同时表示接下来的时期会更大,且基于已有的事物。 首先,看第一部分:刚报告的时期(2016年第四季度和全年)是否被管理层描述为高点。在电话会议中,Giovanni Caforio说:“2016 was a year of strong operational performance for the company with 17% growth in sales and 41% growth in non-GAAP earnings.” 这表示2016年销售增长17%,非GAAP盈利增长41%,这是强劲的表现。但这是否是“最强”或“高点”?管理层没有明确说这是“record”或“best”,但“strong operational performance”和“17% growth”可能暗示强劲。然而,我们需要看是否明确为高点。另外,在回答中,管理层提到“we are very proud of our innovation in immuno-oncology”,但并没有明确说这是公司历史上最强的时期。可能更倾向于“strong”而非“strongest”。但我们需要看是否有“high point”的表述。在电话会议中,没有明确说“这是最好的时期”或“创纪录”。所以可能第一部分不够明确。 再看第二部分:接下来的时期(2017年)是否被描述为更大,且基于已有的事物。管理层对2017年的展望:对于Opdivo,他们预计全球增长,但美国可能持平或略有增长。对于整体,他们没有说2017年会比2016年更大,而是说“we expect Opdivo to grow globally”,但美国可能持平。另外,他们提到“we expect to see continued growth internationally in 2017”和“I expect to see continued growth for melanoma and renal as well as from our recently launched head-and-neck indication and the expected bladder approval.” 但这是“continued growth”而非“step above”。而且,他们提到“our second-line business will face increasing competitive pressure in 2017”,所以可能不是更大。此外,他们调整了2017年EPS指引,因为外汇和Keytruda/chemo的潜在进入,所以可能不是更大。管理层没有明确说2017年将比2016年更大,而是说“continued growth”在某些领域,但整体可能持平或略有增长。而且,他们提到“we expect Opdivo to grow globally, driven by our international business. In the U.S., we expect Opdivo will be roughly flat with the potential to show growth”,所以美国可能持平,国际增长,但整体是否更大?没有明确说。 另外,关于“already in hand”的部分,他们提到“we completed price negotiations for France and Germany”和“we have a broad front-line lung cancer program”,但这些是已有的,但并没有说这些将导致2017年比2016年更大。实际上,他们提到“our 2017 guidance takes account of the continued declining contribution of virology and the growth of Eliquis”,所以整体可能不是更大。 因此,管理层没有明确将2016年描述为“最强”或“高点”,也没有明确说2017年将比2016年更大。他们说的是“strong performance”和“continued growth”,但这不是“step above”。所以答案应该是NO。 另外,注意问题要求“ONE coherent staircase pattern with BOTH halves present”,即两个部分都要有。这里可能都不满足。 因此,答案NO。

← Back to the full BMY analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management present the just-reported period as one of the STRONGEST STRETCHES OF BUSINESS THE COMPANY HAS HAD IN ITS RECENT HISTORY — and, in the same breath, tell investors that the PERIOD DIRECTLY AHEAD IS SET TO BE BIGGER STILL, grounding that near-term step-up in things the company ALREADY HAS IN HAND rather than in hopes about the market? Answer YES when management's own words convey, in whatever form fits the business, ONE coherent staircase pattern with BOTH halves present: (1) THE PERIOD JUST FINISHED WAS A HIGH POINT, IN MANAGEMENT'S OWN TELLING. Management characterizes the recent period's business — its orders, volumes, customers, activity, output, wins, or overall performance — as among the strongest the company has recently produced: a record or near-record stretch, a clear high-water mark versus the company's own recent past, or plainly described as the best the business has been running in a long while. The strength must be about real activity that already happened, in whatever terms fit the industry, and must be management's own framing rather than a number an analyst characterizes as strong. (2) THE VERY NEXT STRETCH IS DESCRIBED AS BIGGER, FOR REASONS ALREADY IN HAND. Management indicates that the period immediately ahead — the coming quarter, season, or comparable near-term stretch — is expected to step ABOVE the high point just reported, and supports that expectation with things that already exist or are already committed: orders or bookings already received, work already sold or scheduled, customers already ramping, capacity or product already coming online, commitments already signed, or activity already running at a higher pace than the reported period's average. The essence is that the next step of the staircase is already under the company's feet — management can point to it — rather than something that requires demand to improve, markets to recover, or new business to be won first. Answer NO if the reported period is weak, mixed, merely in-line, or only recovering toward past levels, with no recent high point in management's own framing. NO if management describes the strong period as a peak, one-time bulge, pull-forward, or level it expects to come back down from. NO if the next period is guided flat, down, or merely 'continued strong' without a described step above the level just reported. NO if the expected step-up rests mainly on hoped-for demand, seasonality alone, market recovery, pipeline conversion, or deals not yet closed rather than on business or capability already in hand. NO if either half appears only in an analyst's question or model that management does not itself affirm. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
ADSK Autodesk, Inc. Q3 2019 2018-11-20 A
UPLD Upland Software, Inc. Q4 2017 2018-03-08 C+
GPOR Gulfport Energy Corporation Q4 2016 2017-02-14 A
HPP Hudson Pacific Properties, Inc. Q4 2015 2016-02-25 C

How the model reasoned

GPOR · Q4 2016 → YESThe question is: Does management present the just-reported period as one of the strongest stretches of business the company has had in its recent history — and, in the same breath, tell investors that...YES The transcript shows management framing 2016 as a defining year with record production growth (32% YoY) and reserves increases, calling it a high point in their own words ("another year of record production growth"). For 2017, they announce a $1B–$1.1B capital budget 45–53% higher production growth, grounded in the SCOOP acquisition (already closed or closing), doubled Utica rig count, and existing acreage/hedges—not market hopes. They also note Q1 2017 activity ramping to four net wells turned-to-sales.
UPLD · Q4 2017 → YESThe question is: Does management present the just-reported period as one of the STRONGEST STRETCHES OF BUSINESS THE COMPANY HAS HAD IN ITS RECENT HISTORY — and, in the same breath, tell investors that...YES Management frames Q4 as an "incredibly strong close" with a "record 44% revenue growth" and 1,300-basis-point EBITDA margin expansion to 35%, calling it the 14th consecutive quarter of beating guidance and part of an "outstanding year.
HPP · Q4 2015 → YESThe question is: Does management present the just-reported period as one of the strongest stretches of business the company has had in its recent history — and, in the same breath, tell investors that...YES Victor Coleman explicitly frames 2015 as a “banner year” and “landmark year” with “strong fourth quarter earnings,” “all-time high” demand in Q4, and “impressive” results that “rounded out” the year.

More from the question bank

Selling the shovels to a customer who just gCheap-to-serve incremental businessConviction backed by things in handQ&A has flipped from problems to possibilitiRoom to raise the ceilingBreak from their own historyAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.